Clinical Trial Update: Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study [Phase 1]

View source ↗

Summary

Phase 1 safety study of Poly-ICLC aimed at preventing respiratory viral infections has completed, evaluating its safety in conditions including influenza, acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease
• Respiratory Distress Syndrome
• Smallpox

Drugs mentioned

• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza, Severe Acute Respiratory Distress Syndrome | Phase 1 | Status: COMPLETED